Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Inhaled Nitric Oxide in Infants with Respiratory Failure
NCT00005773Phase 3Terminated
- Sponsor
- NICHD Neonatal Research Network
- Start
- Aug 1998
- Primary completion
- May 2001
- Modality
- DNA Intercalators/Alkylators, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 3 trial of nitric oxide in respiratory failure, persistent pulmonary hypertension of the newborn (PPHN), sponsored by NICHD Neonatal Research Network. Started Aug 1998; status: terminated.
02
Drugs
nitric oxide
03
Conditions
respiratory failurepersistent pulmonary hypertension of the newborn (PPHN)
Beyond the preview
Go deeper on NCT00005773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005773.